Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CEL SCI CORP Regulatory Filings 2018

Jul 13, 2018

34401_prs_2018-07-13_8ffca1a4-9fca-4121-bf0e-38865dc3f19a.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

424B3 1 cvm_424b3.htm PRIMARY DOCUMENT Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2018 Issuer Direct Corporation Untitled Document

| PROSPECTUS
SUPPLEMENT | Filed
pursuant to Rule 424(b)(3) |
| --- | --- |
| (To Prospectus
Supplement dated December 8, 2016) | Registration No. 333-205444 |

CEL-SCI CORPORATION

Series DD and Series EE Warrants

On July 10, 2018 the Company extended the expiration date of its Series DD and Series EE warrants until the close of business on December 10, 2018. The Series DD and Series EE warrants were issued as part of a financing on December 8, 2016. As a result of the reverse stock split approved by the Company’s shareholders and adopted by the Company’s directors:

the holders of the Series DD warrants are entitled to purchase 1,360,960 shares of the Company’s common stock at an exercise price of $4.50 per share; and

the holders of the Series EE warrants are entitled to purchase 1,360,960 shares of the Company’s common stock at an exercise price of $4.50 per share.

Prospectus Supplement dated July 11, 2018

page break